nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—VEGFA—age related macular degeneration	0.933	1	CbGaD
Gliclazide—VEGFA—Angiogenesis—TIMP3—age related macular degeneration	0.00445	0.0668	CbGpPWpGaD
Gliclazide—ABCC8—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.00395	0.0593	CbGpPWpGaD
Gliclazide—ABCC8—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.00352	0.0528	CbGpPWpGaD
Gliclazide—VEGFA—VEGF binds to VEGFR leading to receptor dimerization—KDR—age related macular degeneration	0.00275	0.0413	CbGpPWpGaD
Gliclazide—VEGFA—VEGF and VEGFR signaling network—KDR—age related macular degeneration	0.0023	0.0345	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—SERPING1—age related macular degeneration	0.00211	0.0316	CbGpPWpGaD
Gliclazide—VEGFA—Glypican 1 network—TGFBR1—age related macular degeneration	0.00204	0.0306	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—TIMP3—age related macular degeneration	0.00203	0.0305	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—COL10A1—age related macular degeneration	0.00203	0.0305	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.00201	0.0301	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—TIMP3—age related macular degeneration	0.00201	0.0301	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.00155	0.0232	CbGpPWpGaD
Gliclazide—VEGFA—S1P1 pathway—KDR—age related macular degeneration	0.00138	0.0207	CbGpPWpGaD
Gliclazide—VEGFA—Angiogenesis—KDR—age related macular degeneration	0.00114	0.0171	CbGpPWpGaD
Gliclazide—ALB—HDL-mediated lipid transport—CETP—age related macular degeneration	0.00113	0.017	CbGpPWpGaD
Gliclazide—CYP2C19—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.00108	0.0162	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.000935	0.014	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.000889	0.0133	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.000887	0.0133	CbGpPWpGaD
Gliclazide—VEGFA—HIF-2-alpha transcription factor network—KDR—age related macular degeneration	0.000864	0.013	CbGpPWpGaD
Gliclazide—VEGFA—VEGFR2 mediated cell proliferation—KDR—age related macular degeneration	0.000864	0.013	CbGpPWpGaD
Gliclazide—VEGFA—EPHA-mediated growth cone collapse—KDR—age related macular degeneration	0.000864	0.013	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.000785	0.0118	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by TCPTP—KDR—age related macular degeneration	0.000759	0.0114	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—SERPING1—age related macular degeneration	0.000744	0.0112	CbGpPWpGaD
Gliclazide—VEGFA—Beta3 integrin cell surface interactions—KDR—age related macular degeneration	0.000716	0.0107	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.000709	0.0106	CbGpPWpGaD
Gliclazide—ALB—Lipoprotein metabolism—LIPC—age related macular degeneration	0.000673	0.0101	CbGpPWpGaD
Gliclazide—ALB—Lipoprotein metabolism—CETP—age related macular degeneration	0.000649	0.00974	CbGpPWpGaD
Gliclazide—ALB—HDL-mediated lipid transport—APOE—age related macular degeneration	0.000599	0.00899	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—KDR—age related macular degeneration	0.000564	0.00846	CbGpPWpGaD
Gliclazide—VEGFA—Integrins in angiogenesis—KDR—age related macular degeneration	0.000528	0.00792	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—F13B—age related macular degeneration	0.000513	0.00769	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—CD36—age related macular degeneration	0.000504	0.00757	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	0.000499	0.00749	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—KDR—age related macular degeneration	0.000496	0.00745	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—C3—age related macular degeneration	0.000483	0.00724	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—SERPING1—age related macular degeneration	0.000482	0.00723	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00048	0.00721	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.000461	0.00691	CbGpPWpGaD
Gliclazide—ALB—Lipid and lipoprotein metabolism—LIPC—age related macular degeneration	0.000447	0.00671	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—CCL2—age related macular degeneration	0.000441	0.00662	CbGpPWpGaD
Gliclazide—ALB—Lipid and lipoprotein metabolism—CETP—age related macular degeneration	0.000431	0.00647	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—RAD51B—age related macular degeneration	0.000418	0.00627	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.000414	0.0062	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000413	0.00619	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—SLC16A8—age related macular degeneration	0.000388	0.00583	CbGpPWpGaD
Gliclazide—VEGFA—EPH-Ephrin signaling—KDR—age related macular degeneration	0.000383	0.00575	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000368	0.00552	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000368	0.00552	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—KDR—age related macular degeneration	0.000345	0.00518	CbGpPWpGaD
Gliclazide—ALB—Lipoprotein metabolism—APOE—age related macular degeneration	0.000344	0.00516	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.00033	0.00495	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—KDR—age related macular degeneration	0.000326	0.00489	CbGpPWpGaD
Gliclazide—CYP2C19—Melatonin metabolism and effects—APOE—age related macular degeneration	0.000317	0.00476	CbGpPWpGaD
Gliclazide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—age related macular degeneration	0.000304	0.00456	CbGpPWpGaD
Gliclazide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—age related macular degeneration	0.000268	0.00402	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NMNAT1—age related macular degeneration	0.000245	0.00367	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NMNAT1—age related macular degeneration	0.000237	0.00356	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.000233	0.0035	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00023	0.00345	CbGpPWpGaD
Gliclazide—ALB—Lipid and lipoprotein metabolism—APOE—age related macular degeneration	0.000229	0.00343	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.000225	0.00338	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.000224	0.00336	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—KDR—age related macular degeneration	0.000218	0.00327	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ELOVL4—age related macular degeneration	0.000214	0.00321	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ELOVL4—age related macular degeneration	0.000207	0.00311	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.000189	0.00284	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—CRP—age related macular degeneration	0.000187	0.00281	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RDH8—age related macular degeneration	0.000187	0.0028	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000182	0.00273	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—F13B—age related macular degeneration	0.000181	0.00271	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—CD36—age related macular degeneration	0.000178	0.00267	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—SLC16A8—age related macular degeneration	0.000172	0.00259	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SERPING1—age related macular degeneration	0.00017	0.00255	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00017	0.00254	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SLC16A8—age related macular degeneration	0.000167	0.00251	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RPE65—age related macular degeneration	0.000163	0.00245	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000155	0.00232	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.000154	0.00231	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.000149	0.00223	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—RAD51B—age related macular degeneration	0.000147	0.00221	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—KDR—age related macular degeneration	0.000142	0.00214	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000139	0.00209	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.000137	0.00206	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000133	0.002	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ABCA4—age related macular degeneration	0.000132	0.00198	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000127	0.0019	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.000122	0.00183	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000119	0.00178	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000119	0.00178	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CD36—age related macular degeneration	0.000118	0.00176	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—CD36—age related macular degeneration	0.000115	0.00173	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RHO—age related macular degeneration	0.000115	0.00172	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—KDR—age related macular degeneration	0.000102	0.00152	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—LIPC—age related macular degeneration	8.82e-05	0.00132	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—LIPC—age related macular degeneration	8.56e-05	0.00128	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CETP—age related macular degeneration	8.51e-05	0.00128	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—VEGFA—age related macular degeneration	8.47e-05	0.00127	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CETP—age related macular degeneration	8.25e-05	0.00124	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	8.07e-05	0.00121	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	7.89e-05	0.00118	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NMNAT1—age related macular degeneration	7.89e-05	0.00118	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	7.08e-05	0.00106	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ELOVL4—age related macular degeneration	6.89e-05	0.00103	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	6.46e-05	0.000969	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFBR1—age related macular degeneration	6.43e-05	0.000965	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	6.39e-05	0.000958	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	6.19e-05	0.000929	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	6.16e-05	0.000925	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	5.86e-05	0.000879	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SQSTM1—age related macular degeneration	5.83e-05	0.000875	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	5.73e-05	0.00086	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	5.64e-05	0.000847	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC16A8—age related macular degeneration	5.56e-05	0.000834	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	5.53e-05	0.00083	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	5.23e-05	0.000785	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CD36—age related macular degeneration	5.12e-05	0.000768	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	5.04e-05	0.000757	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	4.99e-05	0.000748	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CD36—age related macular degeneration	4.96e-05	0.000744	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	4.55e-05	0.000682	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—APOE—age related macular degeneration	4.51e-05	0.000677	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—APOE—age related macular degeneration	4.38e-05	0.000657	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CD36—age related macular degeneration	4.07e-05	0.00061	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	3.76e-05	0.000564	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	3.7e-05	0.000556	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—C3—age related macular degeneration	3.7e-05	0.000556	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APOE—age related macular degeneration	3.45e-05	0.000517	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—KDR—age related macular degeneration	3.38e-05	0.000507	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	3.33e-05	0.000499	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	3.27e-05	0.00049	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	3.03e-05	0.000455	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	2.93e-05	0.00044	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL2—age related macular degeneration	2.9e-05	0.000435	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LIPC—age related macular degeneration	2.84e-05	0.000427	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CETP—age related macular degeneration	2.74e-05	0.000412	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	2.67e-05	0.000401	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LIPC—age related macular degeneration	2.55e-05	0.000383	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CETP—age related macular degeneration	2.46e-05	0.00037	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LIPC—age related macular degeneration	2.33e-05	0.000349	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CETP—age related macular degeneration	2.25e-05	0.000337	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VEGFA—age related macular degeneration	1.94e-05	0.000291	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CD36—age related macular degeneration	1.65e-05	0.000247	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CD36—age related macular degeneration	1.48e-05	0.000222	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOE—age related macular degeneration	1.46e-05	0.000218	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CD36—age related macular degeneration	1.35e-05	0.000203	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOE—age related macular degeneration	1.31e-05	0.000196	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOE—age related macular degeneration	1.19e-05	0.000179	CbGpPWpGaD
